Categories Earnings, Health Care

AngioDynamics misses Q3 earnings

AngioDynamics (NASDAQ: ANGO) posted third-quarter earnings on Tuesday before the regular trading hours. Net sales for the period increased 3% to $86.3 million, while adjusted net profit declined to $0.19 per share from $0.23 a year ago.

The market expected earnings of $0.22 per share on revenue of $88.65 million. Both the top line and bottom line missed the consensus.

An infographic on AngioDynamics' third quarter 2019 earnings results

US net sales in the quarter rose 3.9% to $68.3 million, while international sales edged down 0.3% to $18 million.

CEO CEO Jim Clemmer said, “While we had pockets of softness in our financial performance during the third quarter, our overall performance remains strong, and we are confident that we will achieve our full-year guidance. We saw strong growth contributions during the quarter from AngioVac and Solero, as well as from Fluid Management.”

The Latham, New York-based medical devices firm reiterated its FY 2019 guidance, continuing to expect net sales in the range of $354 to $359 million. Adjusted EPS is projected to be in the range of $0.82 to $0.86.


ANGO ended its last trading session 9.4% higher on Monday. The stock has gained 46% in the trailing 52 weeks.

Last year, AngioDynamics announced that it would acquire privately held medical diagnostic and device company RadiaDyne. The latter designs and develops patient dose monitoring technology to improve cancer treatment outcomes.

This deal added to AngioDynamics’ portfolio RadiaDyne’s early-stage, proprietary real-time radiation dose monitoring platform, and other market-leading oncology solutions.


Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

V Earnings: Key quarterly highlights from Visa’s Q1 2023 financial results

Visa Inc. (NYSE: V) reported first quarter 2023 earnings results today. Net revenues grew 12% year-over-year to $7.9 billion. GAAP net income rose 6% to $4.2 billion while EPS grew

Earnings: Highlights of Intel’s (INTC) Q4 2022 financial results

Intel Corporation (NASDAQ: INTC) Thursday reported a decline in adjusted earnings and revenues for the fourth quarter. The semiconductor giant also provided guidance for the first quarter of 2023. Fourth-quarter

McCormick (MKC) expects to drive sales growth in 2023 through pricing actions and cost savings

Shares of McCormick & Company Inc. (NYSE: MKC) were down over 5% on Thursday after the company missed expectations on its fourth quarter 2022 results and provided a lower-than-expected earnings

Add Comment
Viewing Highlight